Methyl isobutyl ketone-induced hepatocellular carcinogenesis in B6C3F1mice: A constitutive androstane receptor (CAR)-mediated mode of action.
In a National Toxicology Program (NTP) chronic inhalation study with methyl isobutyl ketone (MIBK), increases in hepatocellular adenomas and hepatocellular adenomas and carcinomas (combined) were observed in male and female B6C3F1mice at 1800 ppm. A DNA reactive Mode-of-Action (MOA) for this liver tumor response is not supported by the evidence as MIBK and its major metabolites lack genotoxicity in both in vitro and in vivo studies. Constitutive androstane receptor (CAR) nuclear receptor-mediated activation has been hypothesized as the MOA for MIBK-induced mouse liver tumorigenesis. To further investigate the MOA for MIBK-induced murine liver tumors, male and female B6C3F1, C57BL/6, and CAR/PXR Knockout (KO) mice were exposed to either 0 or 1800 ppm MIBK for 6 h/day, 5 days/week for a total of 10 days. On day 1, mice were implanted with osmotic mini-pumps containing 5-Bromo-2-deoxyuridine (BrdU) 1 h following exposure and humanely euthanized 1-3 h following the final exposure. B6C3F1and C57BL/6 mice had statistically significant increases in liver weights compared to controls that corresponded with hepatocellular hypertrophy and increased mitotic figures. Hepatocellular proliferation data indicated induction of S-phase DNA synthesis in B6C3F1and C57BL/6 mice exposed to 1800 ppm MIBK compared to control, and no increase was observed in MIBK exposed CAR/PXR KO mice. Liver gene expression changes indicated a maximally-induced Cyp2b10 (CAR-associated) transcript and a slight increase in Cyp3a11(PXR-associated) transcript in B6C3F1and C57BL/6 mice exposed to 1800 ppm MIBK compared to controls, but not in Cyp1a1 (AhR-associated) or Cyp4a10 (PPAR-α-associated) transcripts. CAR/PXR KO mice exposed to 1800 ppm MIBK showed no evidence of activation of AhR, CAR, PXR or PPAR-α nuclear receptors via their associated transcripts. MIBK induced hepatic effects are consistent with a phenobarbital-like MOA where the initiating events are activation of the CAR and PXR nuclear receptors and resultant hepatocellular proliferation leading to rodent liver tumors.
The Dow Chemical Company, Midland, MI, USA. Electronic address: bhughes2@dow.com.
B J
BJ
Hughes
The Dow Chemical Company, Midland, MI, USA.
J
J
Thomas
American Chemistry Council, Washington, DC, USA.
A M
AM
Lynch
ToxStrategies, Cary, NC, USA.
S J
SJ
Borghoff
Eastman Chemical, Kingsport, TN, USA.
S
S
Green
Sasol Solvents, Moers, Germany.
T
T
Mensing
Shell International, Houston, TX, USA.
S S
SS
Sarang
The Dow Chemical Company, Midland, MI, USA.
M J
MJ
LeBaron
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D000090702:Constitutive Androstane Receptor; D005260:Female; D019570:Inhalation Exposure; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008742:Methyl n-Butyl Ketone / Q000008:administration & dosage / Q000633:toxicity*; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*
D000090702:Constitutive Androstane Receptor; D018160:Receptors, Cytoplasmic and Nuclear; D008742:Methyl n-Butyl Ketone; C005458:methyl isobutyl ketone
BrdU labeling; CAR/PXR; Knockout mice; Mode of action; Rodent liver